General Skin Cancer


Promising Activity of Pembrolizumab in Merkel Cell Carcinoma (June 14, 2016)

Treatment of 26 patients with advanced previously untreated Merkel cell carcinoma with Keytruda® (pembrolizumab) every three weeks resulted in an overall response rate of 56% suggesting this novel therapy... Continue Reading

National “Check Yourself to Protect Yourself ALL YEAR” Campaign Highlights Need for Year-Round Skin Cancer Prevention (November 12, 2015)

Although one in five Americans will get skin cancer in their lifetimes, 65 percent of people of color don’t believe they are at risk and face lower survival rates as a result. To change these odds,... Continue Reading

Patients with Multiple Squamous Cell Carcinomas Should be Frequently Monitored (October 21, 2015)

Patients with multiple sites of cutaneous squamous cell carcinoma (a type of skin cancer) have a significantly increased risk of developing a recurrence or spread to their lymph nodes, warranting frequent... Continue Reading

New Treatment Options Emerging For Advanced Basal Cell Carcinoma (December 3, 2014)

Basal cell carcinoma is the most commonly diagnosed type of skin cancer. Most cases can be treated with surgery or other types of local treatment and are not life threatening. In the most severe cases,... Continue Reading

Sonidegib Demonstrates Benefit in Advanced Basal Cell Skin Cancer in Phase II Trial (June 13, 2014)

An experimental drug sonidegib (LDE225) appears to markedly shrink tumors in patients with advanced basal cell carcinoma according to results recently presented at the 2014 annual meeting of the American... Continue Reading

May Is National Skin Cancer Detection and Prevention Month (May 1, 2014)

Sun Valley, ID & Fort Worth, TX—OMNI Health Media (OMNI) announces the launch of skin cancer programs for national skin cancer detection and prevention month. As the month of May brings skin cancer... Continue Reading

Surgery May Not Be Best in Elderly Patients with Nonfatal Skin Cancer (June 28, 2013)

Although skin cancer is often treated with surgery, older patients with a limited life expectancy may not benefit from this treatment approach because they may endure complications and not live long... Continue Reading

Some Squamous Cell Skin Cancers Are Deadly (June 19, 2013)

Cutaneous squamous cell carcinoma is usually easily treated with surgery; however, a subsection of patients with specific disease risk factors are more likely to develop metastases and die from the disease,... Continue Reading

Coffee Might Reduce the Risk of Basal Cell Carcinoma (July 11, 2012)

Good news for coffee lovers—drinking caffeinated coffee could lower the risk of developing basal cell carcinoma, according to the results of a study published in Cancer Research. The Harvard study found... Continue Reading

Erivedge Effective in Basal-Cell Carcinoma (June 21, 2012)

The targeted agent Erivedge™ (vismodegib) is associated with tumor responses in patients with locally advanced or metastatic basal-cell carcinoma and may even reduce the rate of new basal-cell carcinomas,... Continue Reading

NSAIDs Might Reduce Risk of Skin Cancer (June 4, 2012)

The use of non-steroidal anti-inflammatory drugs (NSAIDs) such as aspirin and ibuprofen may reduce the risk of developing skin cancer, according to a recent study published in the journal Cancer.[1] Skin... Continue Reading

Aspirin Continues to Look Promising for Cancer Prevention (March 26, 2012)

A combined analysis of 51 randomized trials found that daily aspirin use reduces the risk of new cancer diagnoses as well as the risk of cancer death. These results were published in The Lancet. A growing... Continue Reading

Erivedge Approved for Basal Cell Skin Cancer (February 1, 2012)

The US Food and Drug Administration (FDA) has approved the targeted therapy Erivedge™ (vismodegib) for the treatment basal cell carcinoma of the skin that has spread to other parts of the body or that... Continue Reading

Increased Skin Cancer Risk Among Those with Inflammatory Bowel Disease (November 29, 2011)

People with inflammatory bowel disease (IBD) may be at increased risk of non-melanoma skin cancer, particularly if they receive immune-suppressing medications such as thiopurines. These were the results... Continue Reading

Additional Evidence That Tanning Beds Increase Skin Cancer Risk (November 3, 2011)

According to a study of more than 73,000 women, use of tanning beds increases the risk of three common types of skin cancer: basal cell carcinoma, squamous cell carcinoma, and melanoma. These results were... Continue Reading

Vismodegib Shrinks Advanced Basal Cell Skin Cancers (October 6, 2011)

The investigational targeted therapy vismodegib (GDC-0449) may provide a significant benefit to patients with locally advanced or metastatic basal cell skin cancers. The results of this Phase II clinical... Continue Reading

Erbitux Shows Promise Against Squamous Cell Skin Cancer (August 3, 2011)

Among elderly patients with squamous cell skin cancer that could not be surgically removed, treatment with the targeted therapy Erbitux® (cetuximab) produced a promising rate of disease control. The results... Continue Reading

Stay on Top of Your Family History of Cancer (July 15, 2011)

People who are at high risk of cancer as a result of their family history may be advised to undergo earlier or more intensive cancer screening. Because family history of cancer can change over time, it’s... Continue Reading

Next Page »

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Facebook Twitter RSS